Handbook of Pharmaceutical Controlled Release Technology

56. 57. 58. 59. 60. 61. 62. Robertson, D. N., 1984. In: Zatuchni, G. I., Goldsmith, A.
, Shelton, J. D. and Sciarra, J. J. (Eds.), Long-acting Contraceptive Delivery
Systems, Harper and Row, New York, Chapter 11. Folkman, J. and Long, D. M.,
1964.

Handbook of Pharmaceutical Controlled Release Technology

Author: Donald L. Wise

Publisher: CRC Press

ISBN: 1482289989

Page: 902

View: 784

The Handbook of Pharmaceutical Controlled Release Technology reviews the design, fabrication, methodology, administration, and classifications of various drug delivery systems, including matrices, and membrane controlled reservoir, bioerodible, and pendant chain systems. Contains cutting-edge research on the controlled delivery of biomolecules!

Delivery Systems for Peptide Drugs

A New Long-Acting Injectable Microcapsule System for the Administration of
Progesterone, Fert. ... Microencapsulation of the Peptide Nafarelin Acetate for
Controlled Release, in "Long-Acting Contraceptive Delivery Systems", G. I.
Zatuchni, ...

Delivery Systems for Peptide Drugs

Author: S.S. Davis

Publisher: Springer Science & Business Media

ISBN: 1475799608

Page: 370

View: 412

Recent years have seen enormous advances in the field of protein and peptide engineering and a greater understanding in the way in which biological response modifiers function in the body. It is now possible through the use of recombinant DNA techniques, or by solid phase protein synthesis, to produce significant quantities of a wide variety of regulatory agents that are therapeutically applicable. The list of these response modifiers expands almost daily to include interferons, macrophage activation factors, neuropeptides and agents that may have potential in cardiovascular disease, inflammation, contraception etc. Prospects to use some of these materials in medicine have reached the stage where products have either been approved by regulatory authorities or are the subject of applications as investigatory drugs or as new therapeutic agents. In some uses the pertinent agent will be administered on an acute basis in the form of a simple injection, as, for example, the use of a tissue plasminogen activator for the treatment of coronary infarct. In other cases regulatory proteins and peptides are indicated for chronic therapy and here they will need to be administered by an appropriate delivery system. Unfortunately, the research on delivery systems for peptides and proteins has not kept pace with the rapid progress in biotechnology and, consequently, there are presently few systems that are entirely appropriate for the administration of macromolecular drugs according to complex dosage regimens, (eg intermittent and pulsed therapy). Furthermore essential pharmacokinetic and pharmacodynamic data may be missing.

Female Contraception

Beck LR, Tice TR (1983) Poly (lactic acid) and poly (lactic acid-co-glycolic acid)
contraceptive delivery system. In: Mishell DR Jr (ed) Long-acting steroid
contraception, vol 2. Raven, New York, pp 175–199 3. Beck LR, Cowsar DR,
Lewis DH, ...

Female Contraception

Author: Benno Runnebaum

Publisher: Springer Science & Business Media

ISBN: 3642737900

Page: 443

View: 696

Contraceptives have always provided ground for controversy. This book describes and discusses latest findings concerning the advantages as well as hazard and risk factors of contraception. The clinical impact of oral contraceptives on metabolism is particularly highlighted. In addition, behavioral methods, intrauterine devices, implants and modern approaches in animal and clinical research in the field of immunization against pregnancy are considered. Last, but not least, the book summarizes the complex ethical, religious and political aspects of family planning and contraception.

Recent Advances in Drug Delivery Systems

R. Marchant, A. Hiltner, C. Hamlin, A. Rabinovitch, R. Slobodkin and J.M.
Anderson, J. Biomed. Mater. Res., 17, 301 (1983). J.M. Anderson, R. Marchant
and M. McClurken, in Long-Acting Contraceptive Delivery Systems, G.I. Zatuchni
et al., ...

Recent Advances in Drug Delivery Systems

Author: James M. Anderson

Publisher: Springer Science & Business Media

ISBN: 1461327458

Page: 404

View: 344

The evident rapid expansion of scientific work and intense interest in both experimental and clinical aspects of new drug delivery systems provided strong motivation for planning this symposium. In designing the program, speakers were identified for their particular expertise in a wide range of topics such as dermal delivery systems, pro-drugs, oral prolonged release, rate-controlled drug delivery, the pharmacokinetics of drug release systems, the synthesis of polymeric drug carriers and the refinement of drug delivery pumps. Because of the considerable involvement of diverse scientists from laboratories around the world where investigations relevant to the topic are now being pursued, a deliberate effort was made to invite international leaders in the field to share their knowledge and experimental outcomes. Thus, plenary papers and panel discussions were offered by organic chemists, bioengineers, patholo gists, material scientists, physical chemists, and pharmacokineti cists from academic and industrial laboratories in some dozen countries. This book which records the presentations offered at the sym posium covers a broad array of topics ranging from general overviews of the physicochemical concepts and analytical methodology which underpin the refinement of drug delivery systems and the tissue responses associated with the use of such systems through detailed discussions of a variety of current approaches employed in the development of new systems.

Technical Bulletin

Polymeric considerations in the design of microencapsulated contraceptive
steroids. In: Zatuchni, G. l.; Goldsmith, A.; Sciarra, J. J., eds. Long-acting
contraceptive delivery systems. Philadelphia: Harper and Row: 77—95.
Matschke, G. H. 1977.

Technical Bulletin

Author:

Publisher:

ISBN:

Page:

View: 210

Encyclopedia of Controlled Drug Delivery 2 Volume Set

D.A. Edelman, L.P. Cole, R. Apelo, and P. Lavin, in G.I. Zatuchni, A. Goldsmith,
J.D. Shelton, and J.J. Sciarra, eds., Long-Acting Contraceptive Delivery Systems,
Harper & Row, Philadelphia, 1984, pp. 621–627. S. El-Mahgoub, Contraception ...

Encyclopedia of Controlled Drug Delivery  2 Volume Set

Author: Edith Mathiowitz

Publisher: Wiley-Interscience

ISBN: 9780471148289

Page: 1057

View: 613

Covers all aspects of controlled drug delivery, including human, agricultural and animal applications. The 70 entries, written by an international team of renowned experts, offers A-to-Z coverage of controlled drug delivery systems for researchers in the pharmaceutical and biotechnology industries, agriculture companies, medical device companies, clinical research organizations and medical schools.

Contraceptive Delivery Systems

It can be administered intramuscularly as an efficient , long - acting contraceptive
, depot medroxyprogesterone acetate ( DMPA ) ( 14 ) . It is a potent progestogen
with minimal androgenic but some anti - androgenic properties . It has been ...

Contraceptive Delivery Systems

Author:

Publisher:

ISBN:

Page:

View: 689

Advances in Drug Delivery Systems 3

4 C.G. Pitt and A. Schindler, CAPRONOR” – A biodegradable delivery system for
levonorgestrel, in: G.L. Zatuchni, A. Goldsmith, J.D. Shelton and J.J. Sciarra (Eds.
), Long-Acting Contraceptive Delivery Systems, Harper and Row, Publishers, ...

Advances in Drug Delivery Systems  3

Author: James M. Anderson

Publisher: Elsevier Science Limited

ISBN:

Page: 395

View: 312

Demographic and Programmatic Consequences of Contraceptive Innovations

Contraception with single implants and mini-implants of ST-1435. Pp. 450–455 in
G.I. Zatuchni, A. Goldsmith, J.D. Shelton, and J.J. Sciarra, eds., Long-Acting
Contraceptive Delivery Systems. Philadelphia, Pa.; Harper & Row. Coutinho,
E.M. ...

Demographic and Programmatic Consequences of Contraceptive Innovations

Author: Sheldon J. Segal

Publisher: Springer Science & Business Media

ISBN: 1468457217

Page: 336

View: 783

This volume contains papers presented at the Conference on the Demographic and Programmatic Consequences of Contraceptive In novations, which was sponsored by the Committee on Population and held at the National Academy of Sciences, October 6-7, 1988. The papers consider how new contraceptive methods currently being developed and changes in the use of already available contraceptives could affect contraceptive practice, levels and patterns of abortion use, and the health of women. In addition, several of the papers re view the probable consequences of introducing new technology into family planning programs in developing countries. The Committee on Population sponsored this conference in order to stimulate think ing and to provide a forum for scientists, family planning program managers, and donor agency personnel to exchange information and ideas about these important issues. The committee is publishing these papers to expand the discussion of consequences of contracep tive innovations and to give scientists, policy makers, and members of the public who could not attend the conference an opportunity to learn about new developments in fertility control and their likely consequences for individuals and the societies in which they live. NEED FOR NEW METHODS While a strong case can be made that the pill and the intrauterine device (IUD) have contributed to declines in the level of unintended pregnancies around the world, it is also clear that for many couples existing methods present problems.